baber/WOPTO huggingface dataset:
Patent DE-69504977-D1 (DE)
Inventor: CAZIN BERNARD
IPC: A01K61/00
Filed: 1995-06-28
Granted: 1998-10-29
Abstract: PCT No. PCT/FR95/00857 Sec. 371 Date Dec. 24, 1996 Sec. 102(e) Date Dec. 24, 1996 PCT Filed Jun. 28, 1995 PCT Pub. No. WO96/00500 PCT Pub. Date Jan. 11, 1996A submersible structure for breeding piscicultural species in any aquatic environment that includes at least one frame member shaped and devised to accommodate a plurality of bunches of fibers. A series of frame members containing bunches of fibers can be connected and/or stacked to form modules in which the fibers can collect fish eggs. Preferably, the structure includes buoys which allow the structure to be positioned in medium-depth water, relative to the bottom of the aquatic environment.
Patent DE-69509797-D1 (DE)
Inventor: ZINGER FREDDY
IPC: A61C5/64
Filed: 1995-12-23
Granted: 1999-06-24
Abstract: The device for applying one or several fluids, particularly a multi-component fluid, such as medical tissue or dental adhesives, comprises a head piece (9) having channels (25 to 28) for each fluid extending from an inlet side of the head piece (9) to a connection site of the head piece (9). The tubular body (10) comprises an inlet end facing the connection site of the head piece (9) and an outlet end facing away from the inlet end. The tubular body (10) comprises an outer wall, which, at least sectionally, is configured such that the tubular body (10) is plastically deformable, particularly plastically bendable.
Patent DE-69513126-D1 (DE)
Inventor: LA FETRA ROSS V
IPC: G06F12/16
Filed: 1995-09-13
Granted: 1999-12-09
Abstract: In a process for quickly determining whether there is a cache hit in cache memory systems utilizing error corrected tags, the hit detection process is split into two paths: the first path includes a circuit to check and correct a tag stored in the cache memory and the second path tests the validity of the tag stored in the cache memory by computing the appropriate ECC information using memory address information supplied by the computer CPU and comprising the tag and ECC stored in the cache memory with the CPU address and computed ECC. As the computed ECC is performed in parallel with the cache RAM access, this second path provides hit confirmation faster than the first path which must process the tag and ECC stored in the cache RAM through a ECC check and correction circuit. If a fast hit is confirmed, then the cache memory system can proceed to supply cache data to the CPU. If a fast hit is not confirmed, then the cache memory system waits for the first path to check and correct, if required, the tag stored in the cache and then test the corrected tag. <IMAGE>
Patent DE-69515796-D1 (DE)
Inventor: BALSELLS PETER J
IPC: F16F3/04
Filed: 1995-11-05
Granted: 2000-04-27
Abstract: A coiled spring has two ends and a number of intermediate coils, each coil having a leading portion disposed at a front angle to a normal line to one centreline and a trailing portion disposed at a back angle to the normal line. End coils congruent with the number of intermediate coils, disposed at the two ends and having back angle member, defining a trailing portion of at least one end coil, for locking the two end coils together. The end coil trailing portion having a back angle different from the intermediate coil trailing portion back angle, the end coils having smaller diameters than the intermediate coils. The end coils is a male end extending outwardly from the intermediate coils along a centreline and another of the end coils is a female end disposed interior to the intermediate coils.
Patent DE-69527663-D1 (DE)
Inventor: ITO TOSIKAZU
IPC: B29C48/12
Filed: 1995-02-28
Granted: 2002-09-05
Abstract: The invention provides a method of producing a platelike article having a platelike substrate (12) and a molding (306) formed on a peripheral edge of the platelike substrate (12), using an extrusion die having a cavity for supplying a molding material to the peripheral edge of the platelike substrate (12). The cavity has an orifice of a certain shape for imparting the certain shape to the molding material. The cavity has first and second cavity portions. The peripheral edge of the platelike substrate (12) constitutes at least a part of a periphery of the platelike substrate. The method comprises the steps of: (a) attaching a guide member (300) to the peripheral edge of the platelike substrate (12) such that a first guide portion (302) of said guide member (300) is matched with the peripheral edge of the platelike substrate (12) and thus that the extrusion die is allowed to smoothly move from said first guide portion (302) of said guide member to the peripheral edge of the platelike substrate (12), said first guide portion of said guide member (300) having a thickness that is substantially the same as that of the peripheral edge of the platelike substrate (12); (b) inserting said first guide portion (302) of said guide member (300) into the cavity of the extrusion die such that the first cavity portion is occupied by said first guide portion of said guide member (300); (c) supplying the molding material to the second cavity portion; (d) moving the extrusion die relative to said guide member (300) and the platelike substrate (12) such that the first cavity portion is occupied by said first guide portion (302) of said guide member and then by the peripheral edge of the platelike substrate (12); (e) extruding the molding material from the second cavity through the orifice onto said first guide portion (302) of said guide member (300) and then onto the peripheral edge of the platelike substrate so as to form the molding (306) thereon; and (f) detaching said guide member (300) from said platelike substrate (12). <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>
Patent DE-69527943-D1 (DE)
Inventor: KATO YASUYOSHI
IPC: F01N3/28
Filed: 1995-11-14
Granted: 2002-10-02
Abstract: A catalyst unit comprising a housing having an inlet, an outlet and side walls extending therebetween, said inlet and outlet defining a direction for gas flow therebetween as an axial direction; a plurality of catalyst plate elements mounted within said housing between said inlet and said outlet to form a stack, each catalyst plate element supporting a catalytic material and having parallel ribs spaced across one dimension thereof with flat sections separating the ribs; is characterized in that adjacent catalyst plate elements in said stack are contacted between their respective ribs, whereby the ribs of adjacent catalyst plate elements define a contact angle of 90 DEG  therebetween, and the ribs of at least one catalyst plate elements are arranged at 90 DEG to said axial direction, and opposing edges of said at least one catalyst plate, respectively traversing said inlet and said outlet, are each spaced a distance L from the center of the rib closest thereto and wherein L ≤ 8 T, wherein T is the spacing between the flat sections of adjacent catalyst plate elements. <IMAGE>
Patent DE-69529991-D1 (DE)
Inventor: VAN DEN WIJDEVEN GIJSBERTUS GE
IPC: A61K47/36
Filed: 1995-09-20
Granted: 2003-04-24
Abstract: The invention relates to the use of substantially fully destructurized starch for transdermal applications in humans and animals, in particular the use of solid particles such as implants. The invention further relates to the implants manufactured of substantially fully destructurized starch, in addition to methods for manufacturing the implants.
Patent DE-69531827-D1 (DE)
Inventor: ANTONIO P
IPC: H04B1/712
Filed: 1995-06-22
Granted: 2003-10-30
Abstract: A system and method for adaptively sectorizing channel resources within a digital cellular communication system is disclosed herein. The system includes an antenna arrangement for providing at least first and second electromagnetic beams for receiving a first information signal transmitted by a specific one of a plurality of users, thereby generating first and second received signals. A first set of beam-forming signals are then generated from the first and second received signals. A demodulating receiver is provided for demodulating at least first and second beam-forming signals included within the first set of beam-forming signals, thereby producing first and second demodulated signals. The system further includes a tracking network for tracking multipath information signals, received from various positions and angles of incidence, based on comparison of the first and second demodulated signals.
Patent DE-69601864-D1 (DE)
Inventor: FAISANT GILLES
IPC: B65G47/88
Filed: 1996-01-03
Granted: 1999-04-29
Abstract: PCT No. PCT/FR96/00008 Sec. 371 Date Sep. 23, 1997 Sec. 102(e) Date Sep. 23, 1997 PCT Filed Jan. 3, 1996 PCT Pub. No. WO96/23714 PCT Pub. Date Aug. 8, 1996Pallet separator including a pedal located at a downstream end of a storage chute. The pedal is connected via a tie to a stop such that movement of the pedal by a load causes movement of the stop which retains and separates loads arranged upstream of the load acting upon the pedal. The pallet separator also includes a delay device in the form of a controlled leak jack whose rod stroke extends from a delay start position and a delay end position. The jack is capable of maintaining the stop in an active position for sufficient time to allow removal and handling of the downstream load before arrival of the next load at the end of the chute.
Patent DE-69602266-D1 (DE)
Inventor: ZWART WALTHER
IPC: E04C3/29
Filed: 1996-07-10
Granted: 1999-06-02
Abstract: The invention pertains to a structural member (3) for bridges, floors, and the like which comprises at least one longitudinal girder of trapezoidal, V-shaped or U-shaped or rectangular cross section (3) with a concrete slab (6) provided thereon, wherein the longitudinal girder is made of synthetic material and at least the side parallel to the concrete slab is reinforced with parallel fibres having an embedded modulus of elasticity of more than 50 GPa. The structural member appreciably simplifies the construction of bridges and floors and has a low weight.
Patent DE-69605577-D1 (DE)
Inventor: YOUNG MICHAEL
IPC: B24D11/00
Filed: 1996-11-21
Granted: 2000-01-13
Abstract: The present invention provides a method of making an abrading sheet material comprising knitting a ground structure comprising a shrinkable polyolefin yarn with laid-in looped threads of a material which is preferably harder than that or those of the ground structure, such that the loop threads are raised from a surface of the ground structure, and shrinking the shrinkable yarn of the ground structure to grip the looped threads to lock the loops in place in the ground structure.
Patent DE-69614271-D1 (DE)
Title: Epitheliales membranprotein-1
Inventor: TAYLOR VERDON
IPC: C12N1/21
Filed: 1996-11-22
Granted: 2001-09-06
Abstract: Epithelial membrane protein-1 (EMP-1) was identified as having a high degree of homology with peripheral myelin protein 22 (PMP22) and was expressed predominantly in the digestive tract and the nervous system. EMP-1 and PMP22 define a novel family of transmembrane proteins which are involved in the regulation of cell growth and/or differentiation. Included in the invention are EMP-1 nucleic acids, and expression vectors and host cells for the recombinant production of EMP-1. Nucleic acids are used to detect EMP-1 mutation in biological samples and to treat EMP-1 related conditions by anti-sense or gene therapy. Host cells displaying EMP-1 are used to screen for EMP-1 ligands and for receptor agonists and antagonists.
Patent DE-69626517-D1 (DE)
Inventor: VICKERY H
IPC: C12N15/16
Filed: 1996-06-03
Granted: 2003-04-10
Abstract: Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic  alpha -helix, said residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence:Haa(Laa Laa Haa Haa)2 Laaand their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of corticosteroid induced osteopenia in mammals.
Patent DE-69631158-D1 (DE)
Inventor: BUKRINSKY I
IPC: C07D239/48
Filed: 1996-01-05
Granted: 2004-01-29
Abstract: The present invention encompasses the use of the compounds of formula as given below to detect certain specific protein structures which are present in nuclear localization sequences   <IMAGE>   wherein A is, independently CH3 or CH2CH3 and R is   <IMAGE>   and salts thereof.  and salts thereof.
Patent DE-69634485-D1 (DE)
Inventor: FU RIQIANG-SLIGER BUILDING
IPC: G01R33/44
Filed: 1996-07-15
Granted: 2005-04-21
Abstract: Methods and apparatus for broadband decoupling in nuclear magnetic resonance with chirp and other RF pulses are disclosed. Such methods may include the step of positioning the sample in a static magnetic field. Additional steps may define a first cycle of pulses, such as chirp pulses, wherein at least two of the pulses have a different initial phase angle from each other and may define a second cycle of pulses wherein at least two of the pulses in the second cycle have an initial phase angle different from the initial phase angles of the pulses in the first cycle. Further steps may repeatedly generate a supercycle of the first and second cycles to produce pulses for inverting the longitudinal magnetization in the sample and may also detect the signals emitted by the sample in response to inversion of the longitudinal magnetization. Alternatively, the chirp pulses in the first and second cycles may be defined to sweep a bandwidth of 100 kHz or more. The first and second cycles may also be defined to include linear frequency modulated RF pulses wherein each of the RF pulses has an amplitude which is substantially constant during at least about 50% of the pulses. Apparatus for performing the disclosed methods is also disclosed. Other methods and apparatus are also disclosed.
Patent DE-69637484-D1 (DE)
Inventor: KNAPPIK ACHIM
IPC: C12N15/63
Filed: 1996-08-19
Granted: 2008-05-15
Abstract: The present invention relates to synthetic DNA sequences which encode one or more collections of homologous proteins/(poly)peptides, and methods for generating and applying libraries of these DNA sequences. In particular, the invention relates to the preparation of a library of human-derived antibody genes by the use of synthetic consensus sequences which cover the structural repertoire of antibodies encoded in the human genome. Furthermore, the invention relates to the use of a single consensus antibody gene as a universal framework for highly diverse antibody libraries.
Patent DE-69703980-D1 (DE)
Inventor: CAPOTOSTI ROMEO
IPC: B22D11/06
Filed: 1997-07-09
Granted: 2001-03-01
Abstract: A method for continuously casting thin metal products, the method comprising the operations of pre-heating a pair of refractory plates (7) for the lateral containment of a bath of molten metal constituted of a pair of counter-rotating rolls (1, 2) and of abutting said pair of plates (7) towards each lateral surface of the ends of said pair of rolls (1, 2), characterized in that it comprises the operations of applying a controlled elastic or elastic/plastic deformation to said pair of plates (7) at the contacting arc between the surface of the plates (7) and the peripheral portion of the ends of said rolls (1, 2), and controlling said elastic and/or elastic-plastic deformation of said pair of plates (7) during the whole casting process, so as to minimize the surface wear of the plates (7) and of the ends of the rolls (1, 2), and to guarantee the maintainment of a predetermined distance between said rolls (1, 2) and said plates (7) lower than a predetermined value, and to minimize the occurrence of leaks-of molten metal between said plates (7) and said end parts of said rolls (1, 2).
Patent DE-69704061-D1 (DE)
Inventor: BOUZAGLO GABRIEL
IPC: B65D47/20
Filed: 1997-06-11
Granted: 2001-03-15
Abstract: PCT No. PCT/FR97/01036 Sec. 371 Date Dec. 14, 1998 Sec. 102(e) Date Dec. 14, 1998 PCT Filed Jun. 11, 1997 PCT Pub. No. WO97/47531 PCT Pub. Date Dec. 18, 1997The container stopper comprises a cylindrical part to be engaged in the neck of a container and has a groove which extends peripherally on at least one part of the cylindrical part circumference. Two channels separated from each other, extend in the cylindrical part of the stopper and open into the groove through orifices respectively spaced from each other in the groove peripheral direction. A diaphragm of elastomeric material closely matches the shape of the cylindrical part and the groove surface covering the orifices of the two channels. The diaphragm forms a shut-off valve that by its elastic deformation, allows a fluid substance contained in the container to flow from inside the container outwards, as well as from outside into the said container.
Patent DE-69714757-D1 (DE)
Inventor: KARVONEN LASSI
IPC: B65H27/00
Filed: 1997-10-30
Granted: 2002-09-19
Abstract: A take-out leading roll, spreader roll or equivalent for a web-like material including a non-revolving roll axle having end parts and a middle part situated between the end parts, and a continuous and tubular roll mantle revolvingly journalled by bearings on the roll axle and extending over the end parts and the middle part. The middle part is pivotally linked to the end parts to enable the roll to be bent to a desired arcuate shape. The roll mantle is preferably journalled on the roll axle only in the areas of the roll ends by bearings supported on the end parts of the roll axle. The material of the roll mantle is preferably a composite material.
Patent DE-69715301-D1 (DE)
Inventor: DI NAPOLI GUIDO
IPC: A61K31/22
Filed: 1997-04-24
Granted: 2002-10-17
Abstract: The following description sets forth new diacerhein formulations with diacerhein being incorporated into a polysaccharide gel matrix, the process for their preparation, and the pharmaceutical compositions containing same. The gel is preferably a hydrogel of anionic polysaccharides, such as alginates and pectins, containing carboxyl groups at least partially salified with Ca<++> ions. The formulations according to the present invention reduce the occurrence and/or severity of diarrhea episodes when compared with the compositions known to the art and their bioavailability is comparable to or even higher than that of the pharmaceutical compositions marketed commercially.
Patent DE-69717601-D1 (DE)
Inventor: GORDON JULIAN
IPC: C12Q1/68
Filed: 1997-01-22
Granted: 2003-01-16
Abstract: Provided herein is a method for analyzing a target nucleic acid to determine the number of tandemly repeated sequences, which may form a part of the target sequence, relative to a complementary oligonucleotide. Also provided is a target sequence capture reagent for capturing a target sequence which comprises a tandemly repeated sequence.
Patent DE-69718927-D1 (DE)
Inventor: SHELESTAK LARRY J
IPC: C03C4/08
Filed: 1997-06-25
Granted: 2003-03-13
Abstract: The present invention provides a green colored, infrared and ultraviolet absorbing glass article having a luminous transmittance of up to 60 percent. The composition of the glass article uses a standard soda-lime-silica glass base composition and additionally iron, cobalt, selenium, and chromium, and optionally titanium, as infrared and ultraviolet radiation absorbing materials and colorants. The glasses of the present invention have a color characterized by a dominant wavelength in the range of about 480 to 565 nanometers, preferably about 495 to 560 nanometers, with an excitation purity of no higher than about 20 percent, preferably no higher than about 10 percent, and more preferably no higher than about 7 percent. The glass compositions may be provided with different levels of spectral performance depending on the particular application and desired luminous transmittance. In one embodiment of the invention, the glass composition of a green colored, infrared and ultraviolet radiation absorbing soda-lime-silica glass article includes a solar radiation absorbing and colorant portion consisting essentially of about 0.60 to 4 percent by weight total iron, about 0.13 to 0.9 percent by weight FeO, about 40 to 500 PPM CoO, about 5 to 70 PPM Se, about 15 to 800 PPM Cr2O3, and about 0.02 to 1 percent by weight TiO2. In another embodiment of the invention, the glass composition of the article includes a solar radiation absorbing and colorant portion consisting essentially of 1 to less than 1.4 percent by weight total iron, about 0.2 to 0.6 percent by weight FeO, greater than 200 to about 500 PPM CoO, about 5 to 70 PPM Se, greater than 200 to about 800 PPM Cr2O3, and 0 to about 1 percent by weight TiO2.
Patent DE-69723197-D1 (DE)
Inventor: RICHELSOPH MARC
IPC: A61B17/70
Filed: 1997-10-14
Granted: 2003-08-07
Abstract: A transverse connector includes a pair of transverse connector bodies and connector inserts for connecting a rod (e.g. spinal) to each of the transverse connector bodies. A locking and fixing mechanism draws the transverse connector inserts into seat portions of the transverse connector bodies while simultaneously locking the transverse connector inserts in the insert seat portions and compressing a rod seat surface of the inserts to lock a rod within the rod seats. An interconnecting mechanism interconnects the pair of transverse connector bodies along an axis defined by the length of the transverse connector bodies.
Patent DE-69723230-D1 (DE)
Inventor: STAUSS JOSEF
IPC: A61K35/12
Filed: 1997-01-17
Granted: 2003-08-07
Abstract: A method of treating a patient with a disease wherein the patient contains diseased cells which cells contain, or are associated with, an abnormal molecule or an abnormally elevated amount of a molecule and which cells are capable of presenting at least part of said molecule on their surface by an HLA class I (or equivalent) molecule, the method comprising administering to the patient a therapeutically effective amount of cytotoxic T lymphocytes (CTL) which recognize at least part of said molecule when presented by an HLA class I (or equivalent) molecule on the surface of a cell characterized in that the cytotoxic T lymphocytes are not derived from the patient with a disease. Preferably, the CTL are derived from an individual which individual does not carry the HLA class I (or equivalent) molecule type which, in the patient, presents at least part of said abnormal molecule, or molecule abnormally elevated, contained in or associated with the disease cells of said patient.